Acrivon

0 followers


Developing best-in-class targeted therapies to improve the lives of patients.

Industries

Headquarters

Stage

Employees

Links

Org chart

Peter Blume-Jensen
CEO, President & Founder

Peter Blume-Jensen

Collapse
Kristina Masson
Co-Founder, EVP, Business Operations, Site Head, Director
Erick Gamelin
Chief Medical Officer
Eric Devroe
Chief Operating Officer
Rasmus Holm-Jorgensen
Chief Financial Officer
Mary-Alice Miller
General Counsel
Praveen Marapaka
SVP, Global Regulatory Affairs
Adam D. Levy
SVP, Corporate Affairs & Investor Relations
David Proia
VP, Biology & Drug Discovery
John Van Duzer
VP, Chemistry Manufacturing & Controls
Joon Jung
VP & Head, Data Science
Katharine Peterson
VP, Finance & Accounting
James Dunyak
VP, Biostatistics
Bruce Close
VP, Quality & Compliance
Monica Phadnis
VP, Clinical Operations
Michail Shipitsin
Executive Director, Biomarker Development